Latest news
Braveheart Bio’s $382M IPO for Heart Drug Leads a Big Week for Biotech IPOs - MedCity NewsMedCity News · Mon, 10 Aug 2026 03:12:34 GMTFit to fund: UK biotech VC investment surges to five-year high - bioxconomy.combioxconomy.com · Fri, 07 Aug 2026 10:51:38 GMTBiotech Stocks: The New Drugs That Could Fuel Big Gains - Barron'sBarron's · Fri, 07 Aug 2026 05:15:00 GMTBest Biotech Stocks to Buy for August 2026 - Zacks Investment ResearchZacks Investment Research · Thu, 06 Aug 2026 07:00:00 GMTBiotech Investors Are Waiting For The Wrong Milestone In AI Drug Discovery - insights.citeline.cominsights.citeline.com · Tue, 04 Aug 2026 09:24:00 GMTDrugging the undruggable: How biotech innovation is creating opportunities for investors - T. Rowe PriceT. Rowe Price · Sat, 01 Aug 2026 18:00:43 GMTWhy Chinese Biotech Licensing Deals Became Attractive to US Investors - Pharmaceutical ExecutivePharmaceutical Executive · Wed, 29 Jul 2026 07:00:00 GMTMapLight CEO on what investors missed in the biotech’s schizophrenia data - BioPharma DiveBioPharma Dive · Wed, 29 Jul 2026 07:00:00 GMT